MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Colonoscopy Screening: Setting Epic Follow-up Times
Not Applicable
Completed
- Conditions
- Concordance Between Colonoscopy Follow up Interval Noted in Patient Letters vs. Electronic Health Record ChartColorectal Cancer
- Interventions
- Other: Assistance with implementing Epic Smartlist
- First Posted Date
- 2022-11-30
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 43
- Registration Number
- NCT05631873
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
Not yet recruiting
- Conditions
- Rectal CancerNon Metastatic Rectal Cancer
- Interventions
- Other: ctDNA
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05629442
- Locations
- 🇺🇸
Mass General Cancer Center Newton-Wellesley Hospital, Newton, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Virtual Reality Intervention for Patients Undergoing BMT
Not Applicable
Active, not recruiting
- Conditions
- Bone Marrow Transplant Complications
- Interventions
- Behavioral: BMT-VR
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05629676
- Locations
- 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Effect of Automated Real-time Feedback on Early Sepsis Care
Not Applicable
Completed
- Conditions
- Sepsis
- Interventions
- Other: SCTP
- First Posted Date
- 2022-11-23
- Last Posted Date
- 2022-11-23
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 3269
- Registration Number
- NCT05625464
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Methemoglobin Concentration in High Dose Inhaled Nitric Oxide
Early Phase 1
Active, not recruiting
- Conditions
- Healthy Subjects
- Interventions
- Drug: Inhaled Nitric Oxide
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05612074
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
PEERS Plus mHealth Enhanced Peer Support
Not Applicable
Recruiting
- Conditions
- Depression in Old Age
- Interventions
- Behavioral: Peers plus
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05611996
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Losartan in Prevention of Radiation-Induced Heart Failure
Early Phase 1
Recruiting
- Conditions
- Breast CancerMyocardial FibrosisRadiation-Induced Fibrosis
- Interventions
- Radiation: Radiation Therapy
- First Posted Date
- 2022-11-07
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05607017
- Locations
- 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
Not Applicable
Recruiting
- Conditions
- Avoidant/Restrictive Food Intake DisorderDyspepsiaCognitive Behavioral TherapyBehavioral MedicineFeeding and Eating DisordersFunctional DyspepsiaAppetite RegulationPost-prandial Distress Syndrome
- Interventions
- Behavioral: Cognitive Behavioral Therapy
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05587127
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Not Applicable
Recruiting
- Conditions
- AmyloidosisHeart FailureHeart Failure, DiastolicTransthyretin Amyloidosis
- Interventions
- Diagnostic Test: 99mTc-pyrophosphate Scintigraphy
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 515
- Registration Number
- NCT05577819
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
Phase 2
Recruiting
- Conditions
- Anxiety DepressionHIVMajor Depressive Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05570812
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath